Aytu BioPharma, Inc.: shareholders and insiders

AYTUNASDAQHealthcare · Pharmaceutical Preparations

Price

$2.66

November 19, 2026Market cap $51M

What Ploutos Investor adds for Aytu BioPharma

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 13 fiscal years, from FY2014
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 46% since Nov 16, 2026, when the 10-Q these figures come from was filed ($1.82 then, $2.66 on Nov 19, 2026). The figures date from before that move.10-Q
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 20, 2025 to Jul 30, 2026, from their own Form 4 filings.

8 Form 4s

Bought on the market

–

nobody

Sold on the market

–

nobody

From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

No trades under these filters.

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by AYTU's officers and directors from 2016 up to November 19, 2025, 10 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%1 On a 13DAug 14, 2026 Latest filing
  • Nantahala Capital Management, LLCwith 2 more persons
    Share of class14.4%
  • Stonepine Capital Management, LLCwith 3 more persons
    Share of class9.90%
  • AWM Investment Company, Inc.
    Share of class5.80%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Nantahala Capital Management, LLC14.4%From the filing of Jun 9, 2025

    Item 4 is amended by the addition of the following: On June 6, 2025, the Reporting Persons caused the Nantahala Investors to purchase prefunded warrants (the "June 2025 Prefunded Warrants") in an underwritten offering (the "June 2025 Offering") by the Issuer. Using cash on hand, the Nantahala Investors purchased June 2025 Prefunded Warrants exercisable, subject to the terms and conditions thereof, for 4,000,000 shares of Common Stock. The Nantahala Investors purchased the June 2025 Prefunded Warrants for $1.4999 per share of Common Stock represented by the June 2025 Prefunded Warrants. The June 2025 Prefunded Warrant may be exercised at any time by payment of cash in the amount of $0.0001…

    From the filing of Jun 9, 2025
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Lytton Laurence W4.99%Aug 14, 202613G/A
  • Philotimo Fund, LP0.00%Nov 12, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter-74%
  • Renaissance Technologies
    In the quarter+16%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 1.70% of its shares outstanding were held short, -4.7% since the report before.

Shares held short
328.9K
1.70%
Since the report before345.2K on Sep 30, 2026
-4.7%
14.0
23.6K
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 632.8K
  • Nov 15, 2023: Shares held short 602.9K
  • Nov 30, 2023: Shares held short 464.0K
  • Dec 15, 2023: Shares held short 409.8K
  • Dec 29, 2023: Shares held short 376.3K
  • Jan 12, 2024: Shares held short 348.5K
  • Jan 31, 2024: Shares held short 315.1K
  • Feb 15, 2024: Shares held short 334.9K
  • Feb 29, 2024: Shares held short 349.5K
  • Mar 15, 2024: Shares held short 361.6K
  • Mar 28, 2024: Shares held short 360.9K
  • Apr 15, 2024: Shares held short 402.5K
  • Apr 30, 2024: Shares held short 383.0K
  • May 15, 2024: Shares held short 419.4K
  • May 31, 2024: Shares held short 463.3K
  • Jun 14, 2024: Shares held short 455.9K
  • Jun 28, 2024: Shares held short 411.7K
  • Jul 15, 2024: Shares held short 396.2K
  • Jul 31, 2024: Shares held short 372.5K
  • Aug 15, 2024: Shares held short 324.8K
  • Aug 30, 2024: Shares held short 324.0K
  • Sep 13, 2024: Shares held short 315.9K
  • Sep 30, 2024: Shares held short 262.3K
  • Oct 15, 2024: Shares held short 225.2K
  • Oct 31, 2024: Shares held short 192.8K
  • Nov 15, 2024: Shares held short 120.8K
  • Nov 29, 2024: Shares held short 118.4K
  • Dec 13, 2024: Shares held short 126.8K
  • Dec 31, 2024: Shares held short 137.3K
  • Jan 15, 2025: Shares held short 131.6K
  • Jan 31, 2025: Shares held short 127.7K
  • Feb 14, 2025: Shares held short 123.9K
  • Feb 28, 2025: Shares held short 120.4K
  • Mar 14, 2025: Shares held short 114.7K
  • Mar 31, 2025: Shares held short 117.3K
  • Apr 15, 2025: Shares held short 118.7K
  • Apr 30, 2025: Shares held short 135.8K
  • May 15, 2025: Shares held short 740.4K
  • May 30, 2025: Shares held short 416.7K
  • Jun 13, 2025: Shares held short 624.6K
  • Jun 30, 2025: Shares held short 492.4K
  • Jul 15, 2025: Shares held short 527.0K
  • Jul 31, 2025: Shares held short 585.2K
  • Aug 15, 2025: Shares held short 470.8K
  • Aug 29, 2025: Shares held short 464.5K
  • Sep 15, 2025: Shares held short 461.8K
  • Sep 30, 2025: Shares held short 604.2K
  • Oct 15, 2025: Shares held short 612.6K
  • Oct 31, 2025: Shares held short 499.7K
  • Nov 14, 2025: Shares held short 487.4K
  • Nov 28, 2025: Shares held short 457.2K
  • Dec 15, 2025: Shares held short 462.9K
  • Dec 31, 2025: Shares held short 513.2K
  • Jan 15, 2026: Shares held short 542.7K
  • Jan 30, 2026: Shares held short 548.2K
  • Feb 13, 2026: Shares held short 453.5K
  • Feb 27, 2026: Shares held short 471.3K
  • Mar 13, 2026: Shares held short 507.9K
  • Mar 31, 2026: Shares held short 503.4K
  • Apr 15, 2026: Shares held short 502.2K
  • Apr 30, 2026: Shares held short 505.4K
  • May 15, 2026: Shares held short 457.8K
  • May 29, 2026: Shares held short 408.0K
  • Jun 15, 2026: Shares held short 354.4K
  • Jun 30, 2026: Shares held short 348.5K
  • Jul 15, 2026: Shares held short 347.0K
  • Jul 31, 2026: Shares held short 326.2K
  • Aug 14, 2026: Shares held short 321.5K
  • Aug 31, 2026: Shares held short 334.4K
  • Sep 15, 2026: Shares held short 311.6K
  • Sep 30, 2026: Shares held short 345.2K
  • Oct 15, 2026: Shares held short 328.9K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading34.0% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 34.0% of the shares in the reported trades were short sales, against 27.0% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
34.0%
The 14 beforeOct 13, 2026 – Oct 30, 2026
27.0%
Change
+7.0 pts
Short sales a dayon average, of 170.6K shares
58.0K
More than atof 3,666 US-listed companies, same days
9%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 27.8%
  • Oct 14, 2026: Short sales 28%
  • Oct 15, 2026: Short sales 74.8%
  • Oct 16, 2026: Short sales 16.4%
  • Oct 19, 2026: Short sales 33.9%
  • Oct 20, 2026: Short sales 5%
  • Oct 21, 2026: Short sales 73.5%
  • Oct 22, 2026: Short sales 14.4%
  • Oct 23, 2026: Short sales 12.1%
  • Oct 26, 2026: Short sales 23.1%
  • Oct 27, 2026: Short sales 10.1%
  • Oct 28, 2026: Short sales 38.9%
  • Oct 29, 2026: Short sales 63.3%
  • Oct 30, 2026: Short sales 17.5%
  • Nov 2, 2026: Short sales 58.7%
  • Nov 3, 2026: Short sales 31.5%
  • Nov 4, 2026: Short sales 50.3%
  • Nov 5, 2026: Short sales 21.5%
  • Nov 6, 2026: Short sales 30.8%
  • Nov 9, 2026: Short sales 23.1%
  • Nov 10, 2026: Short sales 34.6%
  • Nov 11, 2026: Short sales 39.1%
  • Nov 12, 2026: Short sales 72.7%
  • Nov 13, 2026: Short sales 54.2%
  • Nov 16, 2026: Short sales 50.5%
  • Nov 17, 2026: Short sales 37.5%
  • Nov 18, 2026: Short sales 21.5%
  • Nov 19, 2026: Short sales 13.4%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

558.9K Insiders' shares5.14% Of the company
  • Joshua R. DisbrowChief Executive Officer
    Directly237.2K
  • Jarrett DisbrowChief Business Officer
    Directly76.6K
  • Ryan J SelhornChief Financial Officer
    Directly74.7K
  • Greg PyszczymukaChief Commercial Officer
    Directly56.1K
  • Carl DockeryDirector
    Directly31.2K
  • Vivian H LiuDirector
    Directly29.8K
  • Abhinav JainDirector
    Directly29.5K
  • John Donofrio Jr.Director
    Directly23.8K

A lower bound: it counts only the 8 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

2 ETFs holding it0.00% The largest weight (VXF)
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%

2 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

38 Managers, Q2 2026$11M Value of their positions
  • Q3 2025: Managers 33
  • Q4 2025: Managers 39
  • Q1 2026: Managers 38
  • Q2 2026: Managers 38

Institutional investors by quarter

The fund managers holding AYTU, quarter by quarter, from Q1 2016 to Q2 2025, 35 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 38 managers held 4.92M shares, worth $11M. During the quarter 3 opened a position, 3 closed one, 12 added and 5 trimmed.

The largest holders, Q2 2026

  • Nantahala Capital Management
    In the quarter+100%
  • Stonepine Capital Management
    In the quarter+15%
  • AWM Investment
    In the quarter
  • Vanguard Capital Management
    In the quarter
  • Crown Advisors Management
    In the quarter+38%
  • Diadema Partners
    In the quarter-58%
  • Two Sigma Investments
    In the quarter-14%
  • Renaissance Technologies
    In the quarter+12%
  • Geode Capital Management
    In the quarter+1.1%
  • Citadel Advisors (Griffin)
    In the quarter+34%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Aytu BioPharma's filings show?

Who buys and sells is one part of Aytu BioPharma's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about AYTU's shareholders

Didn't find what you were looking for?

Ask us
Have AYTU's insiders bought or sold?

From Jul 30, 2026 to Jul 30, 2026 Aytu BioPharma's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold AYTU?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $300.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.